Development and validation of a risk prediction model for depression in patients with chronic obstructive pulmonary disease.

BMC Psychiatry

Department of Neurology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Shanghai, 201100, China.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is a prevalent respiratory condition often accompanied by depression, which exacerbates disease burden and impairs quality of life. Early identification of depression risk in COPD patients remains a clinical challenge.

Objective: This study aimed to develop a machine learning-based model to predict depression risk in COPD patients, utilizing interpretable features from clinical and demographic data to support early intervention.

Methods: Data were extracted from the National Health and Nutrition Examination Survey (NHANES), involving 1,638 COPD patients. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9) scale. Feature selection was performed with Boruta and least absolute shrinkage and selection operator (LASSO) algorithms, identifying key predictors from demographic, lifestyle, medical history, and laboratory variables. Nine machine learning models were trained and evaluated, with performance assessed via accuracy, area under the curve (AUC), calibration, and clinical utility metrics.

Results: Significant predictors of depression included sleep disturbances, age, poverty, hypertension, and comorbidities like cardiovascular disease. The Support Vector Machine (SVM) model achieved the highest performance, with an AUC of 0.890 in the validation set and 0.887 in the test set, demonstrating robust discriminative ability and clinical applicability. SHapley Additive exPlanations (SHAP) analysis enhanced model interpretability. Notably, sleep disturbances, younger age, and greater socioeconomic deprivation were associated with an elevated risk of depression.

Conclusion: This study presents a reliable SVM-based model for predicting depression risk in COPD patients, leveraging NHANES data and interpretable features. It offers a valuable tool for early screening and personalized care, with potential to improve mental health outcomes in this population.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224600PMC
http://dx.doi.org/10.1186/s12888-025-06913-1DOI Listing

Publication Analysis

Top Keywords

copd patients
16
depression risk
12
risk copd
12
chronic obstructive
8
obstructive pulmonary
8
pulmonary disease
8
interpretable features
8
sleep disturbances
8
depression
7
risk
5

Similar Publications

Chronic Obstructive Pulmonary Disease (COPD) is a prevalent chronic respiratory disorder characterized by airway inflammation and irreversible airflow limitation. Its marked heterogeneity and complexity pose significant challenges to traditional clinical assessments in terms of prognostic prediction and personalized management. In recent years, the exploration of biomarkers has opened new avenues for the precise evaluation of COPD, particularly through multi-biomarker prediction models and integrative multimodal data strategies, which have substantially improved the accuracy and reliability of prognostic assessments.

View Article and Find Full Text PDF

Background: In patients with moderate COPD, response to pulmonary rehabilitation including exercise training varies according to the presence of peripheral muscle fatigue (pMF) of quadriceps. This study investigates the role of pMF in predicting pulmonary rehabilitation outcomes in more severe COPD patients who have already developed chronic respiratory failure (COPD-CRF).

Methods: A analysis of a prospective randomised controlled trial was performed at Istituti Clinici Scientifici Maugeri Lumezzane (Brescia, Italy), involving 30 COPD-CRF patients undergoing a pulmonary rehabilitation programme comprising 20 endurance training sessions.

View Article and Find Full Text PDF

Predictors of mortality and hospitalised exacerbations in obstructive airway diseases.

ERJ Open Res

September 2025

Department of Bioanalysis, Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.

Background: In Belgium, age-standardised hospital admission and mortality rates for asthma and COPD are higher than the European average. Understanding the factors that lead to a hospitalised exacerbation and/or mortality is needed to optimise patient management.

Methods: Patients ≥18 years old obtaining two claims for drugs for obstructive airway diseases (ATC code R03) in 1 year between 2017 and 2022 were identified in Belgian nationwide claims-based data.

View Article and Find Full Text PDF

Background: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease. However, the biological role of mitochondrial metabolism (MM) in COPD remains poorly understood. This study aimed to explore the underlying mechanisms of MM in COPD using bioinformatics methods.

View Article and Find Full Text PDF